secwatch.observer — SEC 8-K summary
======================================

Issuer:     Renalytix plc (RNLXY)
CIK:        0001811115
Form:       8-K
Filed at:   2024-03-13T23:59:59+00:00
Accession:  0000950170-24-030496
Event type: other
Sentiment:  neutral
Materiality: 0.85
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Renalytix raises ~$12M via two-tranche equity placing at £0.20/share
--------------------------------------------------------------------

- First tranche of 19,986,031 shares closes March 14, 2024, raising ~$5M gross.
- Second tranche (26,815,841 shares) conditional on shareholder approval, raising ~$7M.
- Net proceeds extend cash runway into Q4 2024 from current runway ending April 2024.
- Related parties Christopher Mills and Mount Sinai subscribed for 4M and 9.36M shares respectively.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1811115/000095017024030496/0000950170-24-030496-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1811115/000095017024030496/rnlx-20240312.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-030496

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer